Cinicial trials of Soberana-Pediatria in children 3-11 years of age begin

Havana, june 28, 2021.- Following verification of the candidate’s safety in a group of adolescents aged 12 to 18, clinical trials of Soberana-Pediatria continue with the inclusion of a second group of volunteers in the three to 11 age group, Yury Valdes Balbin, assistant director of the Finlay Vaccine Institute, reported.

Cuba thanks  ALBA-TCP member countries for their support at Summit.

Caracas, June 25, 2021.- Cuba's Foreign Minister Bruno Rodriguez thanked the ALBA-TCP member states for their support in the struggle against the U.S. blockade on Cuba, which for nearly six decades has caused the island damages estimates at 147,853 million dollars.

ALBA-TCP ratifies commitment to Latin American integration

Caracas, Jun 25, 2021.- The Bolivarian Alliance for the Peoples of Our America-People's Trade Agreement (ALBA-TCP) renewed its commitment to unity and cooperation in the face of threats to the stability of the region.

Venezuela becomes the first country to receive Cuban Abdala vaccine

Havana, June 25, 2021.- Venezuela is the first country to receive a Cuban vaccine candidate Abdala, which arrived in the South American nation on Thursday.

REDE DES MINISTERS FÜR AUSWÄRTIGE ANGELEGENHEITEN KUBAS, BRUNO RODRÍGUEZ PARRILLA ZUR VORLAGE DES RESOLUTIONSENTWURFS: “NOTWENDIGKEIT DER BEENDIGUNG DER VON DEN VEREINIGTEN STAATEN VON AMERIKA GEGENÜBER KUBA AUFERLEGTEN WIRTSCHAFTS-, HANDELS- UND FINANZBLOCKADE“